{
 "name": "福永生技",
 "slug": "tw-4183",
 "aliases": [
  "福永生物科技股份有限公司",
  "EPS Bio",
  "4183"
 ],
 "ticker": "4183",
 "industry": "生技醫療業",
 "website": "https://www.epsbio.com.tw/",
 "summary": "福永生技（4183）是上櫃的生技醫療類股公司，2002 年成立，2017 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "福永生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "EPS Bio",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2017-03-09",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2002-10-22",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "郭鳳琳",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "卓振輝",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 238000000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "https://www.epsbio.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 34227,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": -31.03,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": -31.37,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O"
  },
  {
   "claim": "產品許可：EASYMAX Tag Self-Monitoring Blood Glucose System",
   "value": "FDA 510(k) K201258｜美國｜2021-09-01",
   "unit": "",
   "as_of": "2021-09-01",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf20/K201258.pdf",
   "note": "美國510(k)實質等同性許可，非PMA核准；as_of為FDA核准信日期。"
  },
  {
   "claim": "產品許可：MDT2 BLE Self-Monitoring Blood Glucose System",
   "value": "FDA 510(k) K190189｜美國｜2019-11-01",
   "unit": "",
   "as_of": "2019-11-01",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190189.pdf",
   "note": "美國510(k)實質等同性許可，非PMA核准；as_of為FDA核准信日期。"
  },
  {
   "claim": "產品許可：EasyMax BT Self-Monitoring Blood Glucose System",
   "value": "FDA 510(k) K182057｜美國｜2018-08-24",
   "unit": "",
   "as_of": "2018-08-24",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf18/K182057.pdf",
   "note": "美國510(k)實質等同性許可，非PMA核准；as_of為FDA核准信日期。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-4183.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}